Stephen has been an elected member of RCVS Council since 2012, having previously been an appointed member of Council representing the Royal Veterinary College between 2001 and 2009.
In 2016 he was re-elected to Council to serve a further four-year term and currently chairs the Legislation Working Party.
Stephen graduated from Cambridge in 1980 and subsequently spent time as a large animal practitioner. After undertaking further training in equine surgery and diagnostic imaging at the University of Liverpool, he studied for a PhD at the Royal Veterinary College (RVC) before returning to Liverpool as a Lecturer in Equine Orthopaedics.
He went back to the RVC in 1993 to concentrate on equine clinical services and, in 1997, became Head of the Farm Animal and Equine Clinical Department. He was appointed the RVC’s Vice-Principal for Teaching from 2000 to 2013, Deputy Principal from 2013 to 2017 and currently holds the post of Senior Vice-Principal.
Addressing the need for a learning culture in his speech Stephen said: "Veterinary graduates have never had greater knowledge and technical skills than those graduating this year. But this can make their job so much harder when the certainty of scientific knowledge is confronted with the uncertainties of the sick animal, and the increasing number of possibilities for treatment have to be weighted alongside ethical and economic considerations.
"Of his age, but also prophetic of our age, the philosopher Bertrand Russell commented that 'habits of thought cannot change as quickly as techniques with the result that as skill increases, wisdom fails'.
"So it is important that our young professionals are well-prepared in terms of professional, non-technical skills to cope with the sheer variety of challenges that they encounter, and we, as a profession, within our professional model, provide a nurturing learning culture rather than the blame and cover-up culture that the current emphasis on external regulation fosters, so pervasively and distressingly."
Stephen added that his other priorities would be working with the British Veterinary Association and other stakeholders to uphold the College’s first Brexit principle that 'vital veterinary work continues to get done', a project on graduate outcomes, which flows from the Vet Futures project, and the Legislation Working Party.
Dave (pictured right) says he has created the group to address two problems. Firstly, the chronic lack of support for new graduates in their early years leading to avoidable levels of stress and burnout. Secondly, the knock on side-effect of this poor support, that many graduates turn their back on the profession for good, leading to a national skills shortage and recruitment crisis.
Dave said: "Veterinary graduates across the UK have been crying out for more support for years and this lack of support is the main reason for career dissatisfaction and burnout.
"Through a coordinated program of lectures blended with group mentoring and access to a like-minded peer network beyond university, VetX delivers a level of support that is simply not available through any other current means."
Dave is quick to avoid pointing any fingers of blame at practices, saying: "In my experience employers start out with good intentions, but then the reality of clinical life sets in and most just run out of time to deliver the support required. VetX solves this problem by taking much of the mentoring workload away from the practice."
Although the programme is open to all and is designed to complement in-house training, Dave says VetX gives smaller, independent practices the chance to compete with larger corporate groups which offer in-house mentoring schemes in a very cost-effective way.
The VetX programme is now open for enrollment and will take in a maximum of 50 new or recent graduates beginning in September 2017. Dave says early enrollment is advised as places are filling fast.
For more information about VetX or enrolling on the new programme, visit: http://www.drdavenicol.com/vetxclinics
The company says that Prid Delta with grip tail retains the unique properties of Prid Delta, but now comes with a new and easy-to-use grip tail which makes it easier to extract from the cow.
In addition, research and development has enabled Ceva to produce a smaller applicator with a bevelled tip, making it more suitable for use in heifers. Lastly, Ceva says the applicator is more robust, leading to a reliable application and a better user experience.
Carol Atkinson from Ceva said: "Prid Delta with grip tail combines the well-liked features that already existed in Prid, higher progesterone release and the comfort that comes from the triangular shape, with a new and improved tail for easy removal of the product."
According to the company, Prid Delta with grip tail contains 12% more progesterone than a T-shaped device and its larger surface area (29% greater) results in higher progesterone levels in the cow.
Prid Delta with grip tail will be available in wholesalers from 1st August 2017.
In addition, there will be a webinar: Reproductive Management Strategies for High-Producing Dairy Herds, presented by Dr Paul M. Fricke, Ph.D. Professor of Dairy Science and Extension Specialist in Dairy Cattle Reproduction Department of Dairy Science, University of Wisconsin on 27th July at 1:00pm. The webinar, which is being hosted by www.thewebinarvet.com, will cover resynchronisation strategies and synchronisation strategies in heifers.
Ceva is also launching a new app to help veterinary surgeons and farmers improve farm performance and sustainability through better fertility management.
The app will be made available to Prid users only. Further information is available from your Ceva territory manager. If you are a Prid user and would like access to the new app you can also email Ceva: reprodaction-group@ceva.com.
Esteban Gonzalez joins the practice in Southfields, Laindon, from Ars Veterinaria in Barcelona, one of the leading veterinary hospitals in Spain.
Esteban (pictured right with VRCC Clinical Director, Henry L’Eplattenier) graduated at the Autonomous University of Barcelona (UAB) in 2002. After working as a veterinary emergency in Paris for a year, he did an 18-month rotating internship of at the UAB. He then worked for three years in a veterinary hospital as a soft tissue and emergency surgeon.
In January 2009, he began a three-year residency in small animal surgery in Neuilly-sur-Seine, France, under the supervision of Dr Jean-Francois Bardet, one of France’s leading veterinary surgeons.
As part of his training, he made several visits to the US with graduates of American surgery, as well as specialists in oncology, anaesthesia and emergency medicine.
During his residency he published several articles and gave presentations at national and international conferences.
Esteban graduated as a European specialist in surgery and a diplomate of the European College of Veterinary Surgeons (ECVS) in February 2014. He then worked as a specialist surgeon in the UK for two years until last year when he joined Ars Veterinaria.
VRCC says his is the first of a number of planned appointments which will result in two veterinary surgeons appointed to each of the practice’s eight specialities.
The business is also undergoing a rebranding and rebuilding operation that will see the practice renamed as Southfields.
Operations manager Daniel Hogan said: "The recruitment plan will ensure we continue to offer state-of-the-art veterinary medicine across the board — in oncology, soft tissue surgery, orthopaedics, internal medicine, feline medicine, anaesthesia, diagnostic imaging, neurology and cardiology."
Clinical director at VRCC Henry L’Eplattenier said: "Esteban is a hugely experienced and well-respected specialist, who we are delighted has chosen to join the team here.
"Having his kind of expertise adds to our already considerable skill-sets and is part of a major drive to attract some of the best people in the industry to VRCC."
For more information, visit www.vrcc.co.uk.
The award, funded by the Economic and Social Research Council (ESRC) working in partnership with the Department of Health and the Arts and Humanities Research Council (AHRC), is part of the cross-council 'Tackling antimicrobial resistance: behaviour within and beyond the healthcare setting’ call, part of the antimicrobial resistance cross-council initiative supported by the seven research councils in partnership with other UK funders including the Medical Research Council (MRC).
The research team will be led by social scientists at the University of Exeter and includes two veterinary surgeons from the University of Bristol’s School of Veterinary Sciences, together with colleagues at the Innogen Institute of the University of Edinburgh, the British Veterinary Association and leading farm animal veterinary surgeons across the UK.
The researchers say that better, smarter, more rapid and more accessible diagnoses - driving shifts in behaviour associated with diagnostic decision making - represent a critical step to delivering more effective uses of antibiotics in animal health. But improvements in diagnostic development and their relationship to prescription and treatment requires social, governance and technical innovations.
Professor Henry Buller, project lead from the University of Exeter’s School of Geography, said: "This is an exciting opportunity to provide a current assessment of diagnostic and treatment decision practices in the livestock sectors of the UK. Novel and innovative diagnostic tools are currently in development, and our research will generate better understanding of their development as well as the marketing and regulation of these new technologies."
Dr Kristen Reyher, Senior Lecturer in Farm Animal Science, who is the lead on the project at the University of Bristol’s School of Veterinary Sciences, added: "Our research team – the AMR Force – has a track record of working closely with farmers, veterinarians, retailers and government bodies to encourage responsible use of antibiotics. We are excited to have this amazing opportunity to collaboratively generate, evaluate and analyse behaviours and strategies around animal disease diagnosis and to show how innovation in the development of diagnostic tools along with diagnostic regulation and governance can lead to more sensible use of antibiotics across farming systems.
"Working with our partners, we will identify pathways and possibilities for improved diagnostic practice and will trial new diagnostic tools on a series of farms. We are very excited to take our ideas beyond the UK as well, and will conduct pilot and capacity-building research in Tanzania and also partner with a project working in Bangladesh that is co-funded by ESRC and the Centre for Environment Fisheries and Aquaculture Science."
Professor Buller added: "Employment of new diagnostics doesn’t occur in a vacuum. Our team will evaluate the implications these innovations will have for the organisation, cost-effectiveness and efficiency of veterinary practice, as well as for veterinary training. We will identify the changes in behaviour, practice and knowledge necessary to accompany the more widespread adoption of practices that are deemed effective and will assess the regulatory and governance support necessary to encourage use of beneficial practices."
The interdisciplinary team will work alongside diagnostic tool developers and regulators, veterinary practices and professional bodies, farmers and treatment decision makers, veterinary laboratories, the food industry and government regulatory authorities to develop durable and innovative strategies for facilitating and advancing smarter approaches to the use of antibiotics in agriculture.
The work will cover the major livestock species, and will involve seeking opinions from veterinary surgeons across the country, through collaboration with the BVA.
David Barrett, Professor of Bovine Medicine, Production and Reproduction at the University of Bristol’s School of Veterinary Sciences, said: "This is a fantastic opportunity to assess the adaptability and responsiveness of the different animal production sectors - poultry, pigs and cattle - along with a variety of veterinary structures to the trialled innovations in diagnosis and diagnostics, and will determine the likely benefits of these innovations for prescription practice, for animal health and for sustainable livestock production."
Photo: University of Bristol
The video has already been viewed a staggering 4.6 million times.
In the Facebook post and subsequent comments Jodie explained that her 12-year-old rescue bulldog collapses every couple of months. She highlights the dangers of walking flat-faced dogs in hot weather and the choking hazards that eating can present for dogs with an abnormal soft palate.
BVA President Gudrun Ravetz, said: "This is a very distressing video that demonstrates just how serious BOAS (brachycephalic obstructive airway syndrome) is as a condition for those dogs living with it.
"No dog should have to endure the distress of regularly collapsing, though sadly this is a reality for many flat-faced dogs. We would strongly advise anyone with a pet suffering these symptoms to talk to their vet urgently to agree the best way to ensure the health and welfare of their pet. This may include opting for surgery and will definitely include taking special measures in hot weather.
"BVA has been highlighting the significant health problems suffered by flat-faced dogs, such as bulldogs, and asking potential owners to choose healthier breeds or crossbreeds."
Hopefully, Jodie's video might just cause a few potential owners to do precisely that.
Photo: Facebook/Jodie Marsh
Hosted on the Boehringer Academy website, the three-minute quiz involves listening to 15 murmurs and deciding whether each one is clinically significant or not.
After deciding, you'll be told the grade of the murmur and if further investigation should be considered to determine if the dog has cardiomegaly. Boehringer says this is important since dogs with MVD and cardiomegaly are more likely to develop heart failure within 1 to 2 years1.
To register on the Boehringer Academy or take part in the quiz, visit www.boehringer-academy.co.uk.
Reference
Prilactone Next is replacing the spironolactone products Prilactone and Tempora, which will be discontinued.
Prilactone Next is available in three presentations of 10mg, 50mg and 100mg. It comes in easy-break, chewable tablets, designed to make it easier to give the required dose. The 10mg tablet has a two-way split for a dog between 2.5kg and 5kg, while the 50mg and 100mg tablets have a four-way patented clover-shaped design with the 50mg for dogs between 18.1kg and 25kg and 100mg for dogs between 37.6kg and 50kg.
Prilactone Next is available in boxes of three blisters of 10 tablets for the 10mg and 50mg presentations and three blisters of eight tablets for the 100mg presentation, for easy dispensing and storage in practice.
Nicola Barclay, product manager at Ceva Animal Health, said: "Prilactone Next is an improved, easy to administer spironolactone that enables owners to accurately treat their pets and will further enhance our existing cardiology range."
For further information, contact your local Ceva Animal Health territory manager.
The survey - Surveillance use, understanding and engagement across the veterinary profession - is being carried out by the BVA's Surveillance Working Group, which is made up of 12 members of BVA and its divisions who have expertise in veterinary surveillance.
Chair of the BVA Surveillance Working Group, Kate Sharpe, said: "Following several reviews, the surveillance landscape has changed in England and Wales. This survey is your chance to tell us how you engage with the current system, what you value about the surveillance reports produced and to identify areas for improvement. We want to hear from the full breadth of the profession.
"Whilst we know that disease surveillance is a priority for the profession we would like to understand what drives veterinary professionals to engage with the scanning surveillance system as it currently stands and the barriers which prevent or limit engagement.
"This increased understanding will enable BVA to clearly set out its position on current surveillance systems and highlight key questions to pose to the Government in order to improve surveillance delivery, especially as we head into Brexit negotiations."
The survey was drafted by members of the Surveillance Working Group, with representatives from BVA’s specialist divisions, and will be promoted to members of all relevant veterinary associations.
It is the first of a series of surveillance surveys that will also include localised surveys for Northern Ireland and Scotland. Data collected will inform BVA’s policy position ensuring it is representative of disease surveillance across all the UK.
The survey will run until Friday 31 August 2017 and the BVA says that depending on your area of work, will take no longer than 20 minutes to complete. As a thank you, participants will also be entered into a prize draw to win a £100 Amazon Voucher.
Take the survey.
Kit was appointed by RCVS Council at its June meeting, making him responsible for maintaining an overview of the College’s financial affairs, ensuring the College’s financial viability, and making sure proper records and procedures are maintained.
Kit replaces Dr Amanda Boag who was elected Junior Vice-President by RCVS Council at its March meeting. He has been an RCVS Council Member since 2013 and currently sits on the Standards Committee, as well as lecturing, writing and other projects such as teaching at the local primary school. He also works three days a week seeing clinical cases in both referral and primary care practices.
Kit said: "I am very honoured to have been appointed Treasurer, and look forward to continuing Amanda’s careful stewardship of the College finances with the support of other Council members and the team at Belgravia House.
"Due to uncertainties surrounding the impact of Brexit and increasing inflation, RCVS Council decided at its June meeting to increase the annual renewal fees for veterinary surgeons. I am confident that this will keep the College finances in a healthy state, and I look forward to building on Amanda’s legacy ensuring that the College remains steady over the course of my tenure."
At RCVS Day Amanda will also be made Junior Vice-President, and Dr Stephen May will take up the position of RCVS President for 2017-2018.
Delegates came from 31 different countries - as far afield as Brazil, South Korea and Singapore - and attended over 28 hours of CPD which included a pre-Congress day, dentistry wetlabs, five sponsor-led symposia, two masterclasses and a main congress stream covering feline endocrinology and feline cardiology.
There were 18 speakers and feline experts, including Dr Mark Peterson and Prof Claudia Reusch leading on endocrinology, and Kieran Borgeat and Prof Virginia Luis Fuentes presenting the latest findings in cardiology.
ISFM says the initial feedback from delegates was extremely complimentary, comments including: "inspiring speakers that made it so enjoyable as well as informative", "the speakers did very high value lectures and the feline spirit was really present" and "excellent conference – lectures were informative but still practical and useful, and there was a lot of love for cats".
Running alongside the scientific programme was a busy commercial exhibition and a poster room showcasing original research, case series and case reports from 17 individuals who all received a 50% discount on the cost of their congress registration.
On the social side, there was a welcome reception sponsored by Hill's which included a ride on the world’s first vertical cable car. Boehringer Ingelheim stumped up for cocktails and canapes on the first evening, and fish and chips with live music on Brighton Pier on the Friday, and Idexx threw in prosecco and cupcakes after lectures on Saturday afternoon.
This year, ISFM ran a nursing programme which was so popular, it required a change of venue. Sam Taylor, Director of ISFM’s nursing distance education courses who chaired much of the meeting said: "It has been a real pleasure to welcome so many nurses to our Congress. We have been overwhelmed by the response and although we will not always be able to have a nursing stream at congress we will certainly ensure that we run ISFM events for nurses in 2018, so watch this space!"
Next year’s ISFM Congress is being held in the city of Sorrento on the Amalfi coast in Italy. Taking place from 28th June to 1st July, the congress will cover feline urology and feline oncology. Full details of the congress are yet to be published but over 250 delegates in Brighton have already registered their interest.
The briefing highlighted to members of both Houses the vital role the veterinary profession plays in order to ensure that the veterinary resource in clinical practice, public health, government services, academia and research is appropriately considered and effectively used during Brexit negotiations.
Lord Gardiner of Kimble, Parliamentary Under Secretary of State for the Department of Environment, Food and Rural Affairs (Defra), environment spokespeople for the Scottish National Party (SNP) and Plaid Cymru, and other parliamentarians from the Conservatives, Labour, Liberal Democrats, Plaid Cymru and the SNP, joined Crossbenchers, senior civil servants and key stakeholders at the event.
BVA President Gudrun Ravetz delivered a speech highlighting the main asks from the association's Brexit and the veterinary profession report, which was developed through consultation with BVA members, devolved branches, BVA specialist divisions and other key stakeholders.
The report sets out 52 recommendations for the short, medium and long term across seven areas of public policy: veterinary workforce, animal health, animal welfare, food hygiene and safety, veterinary medicines, research and development, and trade.
Addressing attendees, Gudrun said: "We are a relatively small profession, but we are a diverse profession with far-reaching influence and impact in so many areas of political and public life.
"Last week, we were delighted to hear the Defra Secretary of State, speaking to the Today programme, rightly acknowledged the importance of EU vets to the UK economy; from food hygiene and safety, to monitoring disease outbreaks and facilitating trade. This is why BVA is calling on the Government to guarantee the working rights for non-UK EU vets and vet nurses currently working and studying in the UK at the existing level and with no time limit.
"As we progress with the Repeal Bill we are also calling on the Government to ensure we maintain animal health and welfare current standards – and prioritise them in all trade negotiations, so that high standards of animal health, welfare and food hygiene are a unique selling point for the UK. We can only make a success of Brexit if we harness our veterinary resource."
In his speech, RCVS Junior Vice-President Professor Stephen May highlighted the three RCVS Brexit Principles as well as the findings from the College’s recent survey of non-UK EU vets working in the UK. Professor May also made a call for greater certainty from the Government on the status of EU citizens living and working as veterinary surgeons in the UK and for a substantial transition period to prevent potential veterinary workforce shortages, particularly in areas such as public health and food safety.
Professor May said: "Negotiations with our European partners will no doubt be lengthy and complex on all manner of issues that affect the veterinary sector. For everyone concerned, we join other voices in calling for a substantial transition period to any new order created. This will provide us with time to take stock, to understand the implications and to navigate a pathway that safeguards the interests of our sector and the RCVS is determined to work with all its stakeholders, in particular Government and yourselves [parliamentarians], to ensure that vital veterinary work gets done.
"Key to this will be meeting the need for high-quality, capable veterinary surgeons in all sectors. This can only be achieved in the short-term by emphasising the continued welcome and appreciation of all veterinary non-UK nationals working hard for this country, to encourage them to stay, and continued access to graduates of accredited schools from around the world, alongside increased training of UK nationals to meet our ever expanding veterinary needs."
The event was hosted by BVA Honorary Member and RCVS Past-President, Lord Trees MRCVS, who has sat on a number of House of Lords committees and subcommittees that consider and seek to influence the Government’s plans and policy-making during the UK’s exit from the EU.
Lord Trees closed the BVA and RCVS Brexit briefing by encouraging fellow Peers and MPs to capitalise on the evidence-based, science-led perspective that the veterinary profession is able to provide, particularly as Brexit discussions continue to develop.
Lord Gardiner has since publicly recognised the vital role of the veterinary profession, responding to a question in the House of Lords regarding the retention of skilled workers post-Brexit. In his role as Defra Parliamentary Under Secretary of State, Lord Gardiner said:
"I am most grateful to the noble Lord [Teverson] because I was at the BVA and RCVS reception yesterday, where I know a number of noble Lords were also in attendance. This is an important issue and an element of the negotiations that we want to deal with as promptly as possible. Yes, we do rely on and warmly welcome the support we have from EU national vets, who are hugely important to us."
The session will be conducted in the style of the BBC Radio 4 Moral Maze discussion programme, with panelists and witnesses arguing for and against the viewpoint corporatisation is inevitable and will benefit vets and their clients.
Moderated by Madeleine Campbell, Keith Chandler and Karl Holliman will argue for corporatisation and Andrew Harrison and Tim Greet will be against. They will call upon a series of 'witnesses' for detailed questioning before the topic is more broadly debated.
CVS, the UK’s biggest veterinary group now owns more than 410 veterinary practices, of which over 30 are specifically equine or mixed practices.
The latest equine acquisitions include Bell Equine, a one-site Equine Referral Hospital in Kent, in January 2017 and Severn Edge Veterinary Group, a mixed practice with 12 sites in Shropshire, including a six-vet dedicated equine practice, in April 2017.
One line of argument says that the commercial and business advantages of a corporate, together with their scale and diversity, can give veterinary surgeons greater potential for a more flexible career path and advancement within the industry, and a more sustainable working career in equine practice.
On the flip side, there's the removal of any opportunity to buy into ownership, reduced decision-making ability because of adherence to corporate procedures, extra paperwork, longer approval processes and an increased emphasis on the bottom line.
David Mountford, Chief Executive of BEVA said: "The auditorium is usually full to bursting for our Moral Maze sessions because they bring a broader and more engaging dimension to important topics. The statement Corporatisation of equine practices is inevitable and will benefit vets and their clients is bound to generate some stimulating and possibly heated debate."
This year's BEVA Congress will be held at Liverpool Arena Convention Centre, and anyone who registers before 3rd August will receive significantly reduced booking fees.
For more information, visit: www.beva.org.uk.
The Vet Futures Action Plan included a series of 24 work-streams to be completed over five years (2016-2020), building on the six core themes of: animal health and welfare; veterinary professionals’ wider roles in society; the health and wellbeing of veterinary professionals; diverse and rewarding veterinary careers; sustainable businesses and user-focused services; and leadership.
Vet Futures reports that over the last twelve months, key activities have included:
VN Futures
The VN Futures project (Action X of Vet Futures) isolated six ambitions to achieve by 2020, with the shorter time-scale reflecting the faster rate of both turnover and training for veterinary nurses.
A number of development groups have been created, focusing on each of these ambitions and creating specific actions to ensure their completion. Of these:
RCVS President, Chris Tufnell said: "When we launched Vet Futures back in 2014, the scope of the project seemed daunting and some were sceptical of our ability to succeed. However, through a robust process of evidence-gathering, analysis, action planning and now taking action itself, we are starting to make an impact on some of those core areas that are so fundamental to the future of our profession, such as animal welfare, technology, veterinary skills and knowledge, and leadership.
"Our Action Plan set out a five-year timeframe and we have made some really excellent progress in year one. This will form the foundation of work yet to come – although it remains important to ensure we scan the horizon for new issues that will have an impact on the profession, navigating our way through challenges as they arise."
BVA President Gudrun Ravetz added: "The excitement was palpable at the Vet Futures Summit last year and it spurred us on to roll up our sleeves immediately to start working on the Action Plan, and so a lot has been achieved already.
"Many of the actions are interlinked and so BVA, RCVS and the VSC are working closely together to oversee their delivery, but we have been particularly pleased at the high level of engagement and enthusiasm from others. The success of Vet Futures will be in the profession coming together to bring about the changes we need for a sustainable future.”
The ten-programme series stars Cat Henstridge MRCVS, a Midlands-based locum, Cheryl Lucas MRCVS, a Vets4Pets JVP from Essex, Bristol-based James Greenwood MRCVS and Rory Cowlam MRCVS from London.
The documentary follows a wide selection of patients and conditions, from routine stuff like lump removal from a dog and dental work on a cat, through to more obscure things like an obstructed python and surgery on a goldfish.
Cat said: "I am hoping the profession will like it. It definitely features the realistic side of the job!"
To watch the show on iPlayer, visit: http://www.bbc.co.uk/cbbc/shows/the-pets-factor
The programme commences in October 2017 and includes ten days of hands-on practical training based at the CPD Solutions Training Centre in Studley near Birmingham, where surgery tutors will help veterinary surgeons refine their techniques in small group sessions.
CPD Solutions says the main differences with existing PgCert programmes include a stronger emphasis on practical training, a lack of lecture days and the grouping together of practical days in three attendance sessions.
The company says that many current PgCerts run for 2 to five years, so its programme provides an opportunity for those who'd prefer to complete their training and gain a PgCert qualification in a much shorter timeframe.
Susie Coughlan, MD at CPD Solutions said: "Our experience is that vets get the most out of hands-on practical training in a structured and supportive environment, combined with reflective application of their new skills in practice. We set out to replicate this with the new PgCert – all attendance sessions are practical, and the course provides support for developing reflective work-based learning that vets can then use throughout their careers."
David Perrin, Head of Professional Development at the Centre for Work-Related Studies at Chester University said: "The University is proud to be working with CPD Solutions as leading educationalists in the field of veterinary professional development. We have put together a high-quality product that brings together our work-based learning expertise with CPD Solutions specialist knowledge, and this will be of wide interest to practitioners in the field."
For more information, contact CPD Solutions on 0151 328 0444 or visit www.pgcertsurg.com
In the study, the Pirbright - Wageningen research team combined their expertise in both FMDV and mathematical modelling to evaluate the methods and effects of preclinical diagnosis during surveillance (as would be in place during an outbreak), in order to reduce the risk of transmission between herds of cattle on neighbouring farms.
Transmission experiments in cattle were used to collect samples taken from individual animals such as blood, saliva and nasal swabs, and at herd level such as air samples, on a daily basis during the course of infection. The sensitivity of each of these types of samples for the detection of infected cattle during different phases of infection was then quantified.
Dr. Simon Gubbins, Head of Transmission Biology at Pirbright said: "Our results were incorporated into a mathematical model for FMDV transmission in a cattle herd in order to evaluate the impact of early detection and removal of an infected herd on the reduction in the amount of infectious output which could enable transmission of the virus to cattle on a neighbouring farm.
"By using weekly surveillance, clinical inspection alone was found to be ineffective at blocking transmission. This was in contrast to the impact of weekly sampling using saliva swabs of at least ten animals per farm or daily air sampling (for housed cattle), both of which were shown to reduce the risk of transmission substantially."
Dr. José Gonzáles from Wageningen Bioveterinary Research added: "These findings provide a new approach to disease control which could be added to our emergency preparedness programmes. A potential benefit of applying this strategy is a reduction in the number of animals culled unnecessarily, which is likely to happen when traditional strategies such as pre-emptive culling are implemented."
Following these initial results, the Pirbright - Wageningen research team plan to take their approach from the controlled conditions of the laboratory and test it in field trials. If successful, they hope it will help to reduce the social and economic impact of one of the world’s most devastating livestock diseases.
Zoetis says the combined action of selamectin and sarolaner broadens the spectrum and extends the duration of protection so that the product kills fleas and ticks within 24 hours for five weeks, with no drop in efficacy at the end of the dosing period.
Specifically, Stronghold Plus is licensed:
Zoetis says Stronghold Plus is presented in an easy-to-use, low-volume dose that facilitates a gentle, complete application. It is indicated for use in kittens as young as eight weeks.
Alongside the new product, Zoetis has launched a support programme which includes a series of 'Good Medicine Good Business' workshops, designed to help practices grow their preventative health business.
Running throughout the summer months, the workshops will look at the contribution that preventatives make to practice growth and how increasing client engagement via enhanced preventative care can deliver greater medical value.
Scott Wheway, Zoetis product manager said: "Stronghold Plus offers vets a new topical choice that treats the parasites commonly presenting a threat to cats with one convenient monthly dose.
"What’s more, we are underpinning the launch with a practice support programme that will help practices maximise their preventative care by providing better patient outcomes and increased client value."
For further information on the Good Medicine Good Business workshops or an introductory offer on Stronghold Plus, contact your Zoetis account manager or telephone 0845 300 8034.
The new indication adds to the product’s existing claims for the treatment of respiratory disease in both cattle and swine.
The approval was based on data from a multi-centric field trial which enrolled more than 360 sheep on farms in the EU to evaluate the efficacy and safety of a single subcutaneous dose of gamithromycin to treat footrot. Study sites in the UK were included. Merial says the study demonstrated a statistically superior reduction in lameness and a numerically higher reduction in foot lesions versus tilmicosin. On day 21, 97.8% of Zactran treated sheep were no longer lame, compared to 93.3% of the tilmicosin group.
Sioned Timothy, Technical Manager UK and Ireland said: "This is an exciting development in the treatment of footrot throughout the UK and Europe.
"Footrot is an extremely painful disease and is recognised to have a significant impact on welfare and productivity. It can cause rapid weight loss and reduce reproduction rates, significantly impacting sheep farm profitability. Zactran is a highly effective, fast-acting, single shot injectable treatment, and provides a valuable tool for vets and farmers to use when implementing footrot control strategies.
Findlay MacBean, Head of Large Animal Business UK & Ireland, said: "Our goal at Merial is to improve the health and productivity of production animals through innovative solutions. We hope that the addition of this new indication for Zactran does just that, and gives us the opportunity to bring a cost-effective and practical solution for footrot in sheep to the marketplace.
"It also demonstrates our continued commitment to the sheep market and our ongoing investment in this sector. At Merial we always promote best practice, and believe that the addition of this product extension to our portfolio will help farmers achieve better health status in their flocks and ultimately improve farm profitability."
Zactran is available in the EU as a 150 mg/ml solution presented in 50ml, 150ml and 250ml bottles.
For further product information, see the SPC here.
Lynda Maris, NexGard™ Spectra Product Manager said: "The campaign, which is designed to raise awareness of the rising threat from ticks, lungworm and other parasites that can endanger the health of pets and their owners, is reaching millions of pet owners."
A radio day, during which presenter Jenni Falconer and Merial vet Mike Woodhouse (pictured) discussed parasites and called on owners to visit their practice, apparently reached nearly 3 million listeners via 16 radio stations from BBC Radio Guernsey in the south, to Waves radio in Peterhead and Aberdeen.
The campaign has also been promoted with advertising on Newslink, which broadcasts to 287 stations including: Kiss, Capital, Star, Magic, Talk Sport, Classic and Absolute.
Participating practices have been send campaign support packs and Merial has provided educational and competition social media content to share on Facebook and Twitter. According to the company, its campaign Facebook page has reached reached over 1 million unique users in the last 28 days. Over the same period, Merial says 25,000 unique users have received campaign content on Twitter.
Practices can also direct clients to the campaign website www.petparasiteaction.co.uk.
Pet Parasite Action runs throughout June and July, so there's still time to get involved. For more information, contact your Merial Territory Manager, or call the company on 0870 6000 123.
The company says Euthoxin 500mg/ml is a stronger dose than any other pentobarbital injection products currently available on the UK and Irish markets which means less volume per dose and a better return for veterinary surgeons.
Gareth Carr, commercial manager for Chanelle Vet UK, said: "Our aim is to support UK vets by offering high-quality products at competitive prices.
"We have developed Euthoxin with the veterinarian in mind to offer them a cost-effective, low-volume, reliable euthanasia for a wide spectrum of species."
Euthoxin 500 mg/ml launches officially on 3rd July and will be available from wholesale partners in vials of 100ml.
For further information, download the SPC here, visit www.chanellegroup.co.uk or contact your key account manager for information about a launch offer.
The questionnaire asks you about your perceptions of the PDP, with a focus on the guidance made available both by the RCVS and where applicable the resources provided by the BSAVA.
The company stresses that the survey is confidential, and results will be reported in aggregate only; no individual will be identified. It takes 5 minutes and the results will be used to help evaluate and improve the PDP in the future.
Graduates who are currently or have recently completed the PDP are invited to share their views on the PDP: http://app.keysurvey.co.uk/f/1141621/9038/
Employers / mentors of veterinary graduates are invited to share their views on the PDP here: http://app.keysurvey.co.uk/f/1141665/288d/
Zoetis says that Cytopoint works by mimicking the activity of natural antibodies which selectively bind and neutralise canine interleukin-31 (cIL-31), a key cytokine involved in triggering itch in dogs.
The company says that because of the precision and specificity with which Cytopoint acts to target and neutralise cIL-31, it has been shown not to interfere with the immune response, meaning that it does not induce unintended immunosuppression or enhancement.
Dr. Emmanuel Bensignor, a specialist in veterinary dermatology in Paris, France, who participated in field studies conducted in Europe, said: "My personal experience with Cytopoint showed impressive speed of efficacy, significantly reducing itch in dogs from 24 hours onwards.
"Atopic dermatitis is a very common disease in dogs, and the owners I meet are desperate to find a rapid, reliable and safe solution for their suffering dogs. With its once monthly injection, I believe that Cytopoint has the potential to meet pet owners' needs for its convenience.
"European veterinary dermatologists and veterinarians will now have access to a new therapeutic class via this first monoclonal antibody treatment for veterinary use. It is a very exciting innovation which brings a notable improvement to the health and quality of life of the dogs and happiness to their families."
The recommended minimum efficacious dose for the treatment of clinical manifestations of atopic dermatitis in dogs is 1 mg/kg, which can be repeated monthly. Cytopoint will be available in single dose vials containing 10, 20, 30 or 40 mg/kg of lokivetmab.
For more information, visit the European Medicines Agency.
The videos, by BCF in-house vet Ben Sullivan BVSc MRCVS (pictured right), give a step-by-step guide for each of the measurements covered (LA:Ao ratio, EPSS and EF), to enable viewers to get more from their ultrasound equipment.
Ben said: "At BCF we’re always striving to produce educational resources to help our customers make the most of their imaging equipment, and welcome suggestions from all quarters. In recent months we’ve received a large number of requests for help performing basic 2D echocardiographic measurements. In response to those requests we produced this short video series providing a 'how-to' guide for three of the most common measurements encountered in practice."
The videos were filmed using a Vivid iq, the latest cardiac ultrasound scanner from GE.
Ben added: "We hope you find them useful, and welcome suggestions for other topics you’d like to see covered. Please don’t hesitate to visit our website – www.bcftechnology.co.uk – to access the cardiac measurement videos along with a wide range of other learning materials. We have also recently introduced free monthly webinars. The recorded webinars are also available to view at www.bcftechnology.co.uk."
To watch the cardiac measurement videos, visit: http://bit.ly/2rW1BxM
The event is being held in the Bath Assembly Rooms, right in the heart of the city, on Thursday 21st and Friday 22nd September 2017.
Organiser Simon Guiton MRCVS said: "The programme is based on current hot topics for veterinary surgeons and nurses. We've got a great line up of speakers, not to mention everything else that Bath has to offer by way of culture, restaurants and shopping. It sure beats Milton Keynes on a wet Friday afternoon!"
The programme for veterinary surgeons is as follows:
Day One
Day Two
Speakers include Emi Barker, Esther Barrett, Kieran Borgeat, Gwen Covey-Crump, Angie Hibbert, Nicola Kulendra, Shasta Lynch, Natasha Mitchell, Kostas Papasouliotis, Anita Patel, Louise O’Dwyer, Denise Prisk, Suzanne Rudd, Claire Woolford and Holly Witchell.
Early bird tickets on sale at £139 +VAT for one day, £249 +VAT for both days until 30th June.
For more information, visit: http://vetcpdcongress.co.uk